Guillermo
Debén Ariznavarreta

Foto de Guillermo

Foto de Hospital Universitario La Paz

Hospital Universitario La Paz

Madrid, España

Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (5)

2022

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

2021

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
PLoS ONE, Vol. 16, Núm. 9 September

2010

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era
European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328

2008

Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain
Medicina Clinica, Vol. 131, Núm. 12, pp. 441-446
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study
Haematologica, Vol. 93, Núm. 12, pp. 1829-1836

Proxecto CRIS desenvolto en colaboración coa Fundación Dialnet (Universidad de La Rioja)